Dr Ing Hc Stock Performance
| DRPRF Stock | USD 59.39 4.01 6.32% |
The firm owns a Beta (Systematic Risk) of -0.28, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Dr Ing are expected to decrease at a much lower rate. During the bear market, Dr Ing is likely to outperform the market. At this point, Dr Ing hc has a negative expected return of -0.23%. Please make sure to confirm Dr Ing's total risk alpha, and the relationship between the standard deviation and kurtosis , to decide if Dr Ing hc performance from the past will be repeated in the future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Dr Ing hc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Total Cashflows From Investing Activities | -6 B |
DRPRF |
Dr Ing Relative Risk vs. Return Landscape
If you would invest 6,930 in Dr Ing hc on November 9, 2024 and sell it today you would lose (991.00) from holding Dr Ing hc or give up 14.3% of portfolio value over 90 days. Dr Ing hc is currently producing negative expected returns and takes up 2.3408% volatility of returns over 90 trading days. Put another way, 20% of traded pink sheets are less volatile than DRPRF, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Dr Ing Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Ing's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Dr Ing hc, and traders can use it to determine the average amount a Dr Ing's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0981
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DRPRF |
Estimated Market Risk
| 2.34 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Dr Ing is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dr Ing by adding Dr Ing to a well-diversified portfolio.
Dr Ing Fundamentals Growth
DRPRF Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Dr Ing, and Dr Ing fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DRPRF Pink Sheet performance.
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Revenue | 36.76 B | |||
| EBITDA | 9.38 B | |||
| Cash And Equivalents | 5.87 B | |||
| Cash Per Share | 64.53 X | |||
| Total Debt | 9.75 B | |||
| Debt To Equity | 0.65 % | |||
| Book Value Per Share | 251.94 X | |||
| Cash Flow From Operations | 6.42 B | |||
About Dr Ing Performance
By analyzing Dr Ing's fundamental ratios, stakeholders can gain valuable insights into Dr Ing's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Dr Ing has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dr Ing has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Porsche AG engages in automotive and financial services businesses. Porsche AG operates as a subsidiary of Porsche Holding Stuttgart GmbH. Dr ING is traded on OTC Exchange in the United States.Things to note about Dr Ing hc performance evaluation
Checking the ongoing alerts about Dr Ing for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Dr Ing hc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Dr Ing hc generated a negative expected return over the last 90 days |
- Analyzing Dr Ing's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dr Ing's stock is overvalued or undervalued compared to its peers.
- Examining Dr Ing's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dr Ing's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dr Ing's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dr Ing's pink sheet. These opinions can provide insight into Dr Ing's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DRPRF Pink Sheet analysis
When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |